FA
NVAX icon

Faithward Advisors’s Novavax NVAX Stock Holding History

Faithward Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-123,884
Closed -$1.27M – 326
2022
Q4 		$1.27M Buy
123,884
+7,972
+7% +$141K 0.28% 60
2022
Q3 		$2.11M Buy
115,912
+35,769
+45% +$1.55M 0.5% 50
2022
Q2 		$4.12M Buy
80,143
+62,401
+352% +$3.23M 0.92% 33
2022
Q1 		$1.31M Buy
17,742
+1,977
+13% +$176K 0.25% 58
2021
Q4 		$2.26M Sell
15,765
-2,116
-12% -$364K 0.43% 50
2021
Q3 		$3.71M Sell
17,881
-1,477
-8% -$326K 0.72% 37
2021
Q2 		$4.11M Sell
19,358
-2,905
-13% -$532K 0.81% 37
2021
Q1 		$4.04M Buy
+22,263
New +$4.44M 0.9% 28
2020
Q4 		– Sell
-26,663
Closed -$2.89M – 190
2020
Q3 		$2.89M Buy
+26,663
New +$3.25M 0.7% 45

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Faithward Advisors's NVAX Position: Q1 2023 in Review

Faithward Advisors sold out of Novavax (NVAX) in Q1 2023, closing a stake of 123,884 shares — an estimated $1.27M sold.

Faithward Advisors first reported a position in NVAX in Q3 2020 and held it in 9 quarters. The position peaked at $4.12M in Q2 2022. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Faithward Advisors reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Faithward Advisors sold 123,884 Novavax shares in Q1 2023, an estimated $1.27M.
  • Faithward Advisors first reported a position in Novavax in Q3 2020 and held it in 9 quarters.
  • Faithward Advisors's Novavax position peaked at $4.12M in Q2 2022.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Faithward Advisors's 13F filing for Q1 2023, filed 15 May 2023.